Want to see TSE:JWEL full AI Analyst Report?
Jamieson Wellness Inc (JWEL) Ratios
Jamieson Wellness Inc Ratios
TSE:JWEL's free cash flow for Q2 2026 was $-284.00K. For the 2026 fiscal year, TSE:JWEL's free cash flow was decreased by $-2.11M and operating cash flow was $1.83M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.59 | 2.53 | 2.70 | 2.28 | 2.84 |
| Quick Ratio | 1.43 | 1.63 | 1.45 | 1.28 | 1.41 |
| Cash Ratio | 0.24 | 0.26 | 0.25 | 0.17 | 0.08 |
| Solvency Ratio | 0.12 | 0.11 | 0.10 | 0.10 | 0.21 |
| Operating Cash Flow Ratio | 0.47 | 0.36 | 0.22 | 0.33 | 0.53 |
| Short-Term Operating Cash Flow Coverage | 19.92 | 2.23 | 4.20 | 10.43 | 15.44 |
| Net Current Asset Value | $ -234.18M | $ -223.47M | $ -269.52M | $ -323.27M | $ -73.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.26 | 0.40 | 0.36 | 0.23 |
| Debt-to-Equity Ratio | 0.97 | 0.61 | 1.05 | 0.93 | 0.44 |
| Debt-to-Capital Ratio | 0.49 | 0.38 | 0.51 | 0.48 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.48 | 0.45 | 0.49 | 0.48 | 0.30 |
| Financial Leverage Ratio | 2.50 | 2.39 | 2.61 | 2.57 | 1.91 |
| Debt Service Coverage Ratio | 3.67 | 1.88 | 2.94 | 4.78 | 8.44 |
| Interest Coverage Ratio | 4.40 | 5.24 | 4.18 | 6.70 | 13.44 |
| Debt to Market Cap | 0.32 | 0.28 | 0.32 | 0.28 | 0.09 |
| Interest Debt Per Share | 11.90 | 7.90 | 11.58 | 10.06 | 3.86 |
| Net Debt to EBITDA | 3.18 | 2.30 | 3.92 | 3.73 | 1.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.16% | 37.56% | 34.54% | 36.23% | 36.02% |
| EBIT Margin | 14.07% | 13.09% | 13.08% | 15.15% | 16.88% |
| EBITDA Margin | 16.46% | 15.62% | 16.09% | 18.30% | 20.04% |
| Operating Profit Margin | 13.84% | 14.48% | 14.09% | 15.20% | 16.86% |
| Pretax Profit Margin | 10.93% | 10.33% | 9.71% | 12.88% | 15.62% |
| Net Profit Margin | 7.60% | 7.07% | 7.08% | 9.65% | 11.55% |
| Continuous Operations Profit Margin | 7.84% | 6.97% | 6.81% | 9.65% | 11.55% |
| Net Income Per EBT | 69.50% | 68.49% | 72.91% | 74.90% | 73.91% |
| EBT Per EBIT | 78.97% | 71.32% | 68.95% | 84.75% | 92.68% |
| Return on Assets (ROA) | 5.14% | 4.29% | 4.19% | 4.77% | 7.98% |
| Return on Equity (ROE) | 12.86% | 10.28% | 10.91% | 12.24% | 15.23% |
| Return on Capital Employed (ROCE) | 10.93% | 10.26% | 9.54% | 8.73% | 13.37% |
| Return on Invested Capital (ROIC) | 7.81% | 6.74% | 6.64% | 6.51% | 9.83% |
| Return on Tangible Assets | 10.90% | 9.54% | 9.53% | 11.30% | 15.46% |
| Earnings Yield | 4.44% | 3.40% | 3.60% | 3.67% | 3.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.13 | 3.22 | 4.11 | 3.40 | 4.33 |
| Payables Turnover | 5.17 | 5.70 | 5.79 | 2.71 | 4.98 |
| Inventory Turnover | 2.38 | 2.96 | 2.43 | 2.26 | 2.43 |
| Fixed Asset Turnover | 7.01 | 7.08 | 6.33 | 4.90 | 4.65 |
| Asset Turnover | 0.68 | 0.61 | 0.59 | 0.49 | 0.69 |
| Working Capital Turnover Ratio | 3.04 | 2.87 | 3.04 | 3.12 | 3.38 |
| Cash Conversion Cycle | 171.15 | 172.57 | 176.21 | 134.12 | 161.58 |
| Days of Sales Outstanding | 88.47 | 113.43 | 88.80 | 107.22 | 84.31 |
| Days of Inventory Outstanding | 153.24 | 123.21 | 150.46 | 161.56 | 150.51 |
| Days of Payables Outstanding | 70.56 | 64.07 | 63.05 | 134.66 | 73.25 |
| Operating Cycle | 241.71 | 236.64 | 239.26 | 268.78 | 234.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.97 | 1.48 | 0.76 | 1.23 | 1.11 |
| Free Cash Flow Per Share | 1.67 | 1.24 | 0.53 | 0.88 | 0.55 |
| Dividend Paid and CapEx Coverage Ratio | 1.65 | 1.41 | 0.80 | 1.24 | 1.00 |
| Capital Expenditure Coverage Ratio | 6.49 | 6.06 | 3.41 | 3.47 | 1.99 |
| Operating Cash Flow Coverage Ratio | 0.17 | 0.20 | 0.07 | 0.13 | 0.30 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.08 | 0.05 | 0.09 | 0.10 |
| Free Cash Flow Yield | 4.96% | 3.37% | 1.68% | 2.50% | 1.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 22.58 | 29.37 | 27.81 | 27.24 | 30.94 |
| Price-to-Sales (P/S) Ratio | 1.71 | 2.08 | 1.97 | 2.63 | 3.57 |
| Price-to-Book (P/B) Ratio | 2.90 | 3.02 | 3.03 | 3.33 | 4.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.17 | 29.69 | 59.42 | 39.94 | 72.86 |
| Price-to-Operating Cash Flow Ratio | 17.06 | 24.79 | 41.98 | 28.44 | 36.29 |
| Price-to-Earnings Growth (PEG) Ratio | 1.18 | 3.04 | -2.39 | -35.42 | 1.30 |
| Enterprise Value Multiple | 13.59 | 15.62 | 16.16 | 18.09 | 19.40 |
| Enterprise Value | 1.84B | 1.79B | 1.76B | 1.81B | 1.75B |
| EV to EBITDA | 13.59 | 15.62 | 16.16 | 18.09 | 19.40 |
| EV to Sales | 2.24 | 2.44 | 2.60 | 3.31 | 3.89 |
| EV to Free Cash Flow | 26.34 | 34.81 | 78.44 | 50.32 | 79.29 |
| EV to Operating Cash Flow | 22.28 | 29.07 | 55.42 | 35.83 | 39.50 |
| Tangible Book Value Per Share | -2.70 | -2.80 | -3.81 | -5.09 | 0.66 |
| Shareholders’ Equity Per Share | 11.60 | 12.15 | 10.46 | 10.53 | 8.52 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | 0.33 | 0.30 | 0.25 | 0.26 |
| Revenue Per Share | 19.65 | 17.65 | 16.11 | 13.35 | 11.23 |
| Net Income Per Share | 1.49 | 1.25 | 1.14 | 1.29 | 1.30 |
| Tax Burden | 0.70 | 0.68 | 0.73 | 0.75 | 0.74 |
| Interest Burden | 0.78 | 0.79 | 0.74 | 0.85 | 0.93 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.27 | 0.25 | 0.22 | 0.21 | 0.19 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.28 | 1.20 | 0.69 | 0.96 | 0.85 |
Currency in CAD
